SCHEMBL14428965

SCHEMBL14428965

Nc1ncnc2c1ncn2[C@@H]1O[C@H](COCc2ccccc2)[C@@H](OCc2ccccc2)[C@H](OCc2ccccc2)[C@@H](OCc2ccccc2)[C@H]1O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE2A O00408 2/20 0.59
▸ AHCY P23526 2/20 0.59
▸ ADORA1 P30542 3/20 0.56
▸ HSPA5 P11021 1/20 0.54
▸ DOT1L Q8TEK3 3/20 0.54
▸ SLC29A1 Q99808 2/20 0.53
▸ DPP4 P27487 1/20 0.53
▸ MEN1 O00255 1/20 0.53
▸ SLC28A1 O00337 1/20 0.53
▸ MAP3K7 O43318 1/20 0.53
▸ SLC28A2 O43868 1/20 0.53
▸ GAPDH P04406 1/20 0.53
▸ ADORA3 P0DMS8 1/20 0.53
▸ MAPK1 P28482 1/20 0.53
▸ ADORA2A P29274 1/20 0.53
▸ ADORA2B P29275 1/20 0.53
▸ STAT6 P42226 1/20 0.53
▸ PI4KA P42356 1/20 0.53
▸ KMT2A Q03164 1/20 0.53
▸ SMN1; SMN2 Q16637 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14429257 1.00 PDE2A (0.59) PDE2AAHCYADORA1HSPA5DOT1L
SCHEMBL11427985 0.92 PDE2A (0.64) PDE2AAHCYADORA1HSPA5DOT1L
SCHEMBL5961364 0.92 PDE2A (0.64) PDE2AAHCYADORA1HSPA5DOT1L
SCHEMBL14429059 0.89 TYMP (0.57) PDE2AAHCYADORA1SLC29A1ADORA3
SCHEMBL14429057 0.89 PDE2A (0.59) PDE2AAHCYADORA1HSPA5DOT1L
SCHEMBL14429024 0.89 PDE2A (0.71) PDE2AAHCYADORA1HSPA5DOT1L
SCHEMBL622588 0.89 ADORA1 (0.69) PDE2AAHCYADORA1HSPA5DOT1L
SCHEMBL10431915 0.87 AHCY (0.62) PDE2AAHCYADORA1HSPA5DOT1L
SCHEMBL7906337 0.85 HSPA5 (0.62) PDE2AAHCYADORA1HSPA5DOT1L
SCHEMBL22458248 0.84 ADORA1 (0.65) AHCYADORA1HSPA5DOT1LSLC29A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070185063-A1 Seven-membered ring nucleosides IDENIX PHARMACEUTICALS, INC. 2007-08-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185063-A1 Seven-membered ring nucleosides NSUN2, NSUN3, HAVCR2 PDE2A 3198/4885AHCY 531/4885ADORA1 678/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback